Robert Bosch Venture Capital, Samsung Catalyst Fund and Dell Technologies Capital backed an Atomico-led round that doubled the machine intelligence startup's total funding.

Novartis and Sanofi-Genzyme have co-led a first funding round for NeuroVia, which will use the cash to advance development of a drug for a rare genetic neurological disease.

The personalised marketing technology producer has increased its series C to $31m, with Deutsche Telekom joining a round that already included Baidu.

Medical device developer Amphora Medical has closed a $35.5m series B round co-led by Boston Scientific that will fund a pivotal study for its OAB treatment.

Existing investor Robert Bosch Venture Capital came back for an Information Venture Partners-led series B round that took Flybit's overall funding to $14m.

Naver joined subsidiaries NHN Investment Corp and Line for a series A round announced at the same time as the launch of Syte.ai's clothing search platform.

Bright.md, the provider of a virtual healthcare service backed by StartX, has raised $8m in its latest funding round.

IP Group has upped its bid for Touchstone to $640m and gained the approval of Imperial College London, making a takeover more likely.

Lundbeck's corporate venturing unit contributed to a series C round led by New Enterprise Associates which will advance Trevi Therapeutics' lead pruritus treatment.